Key result
HeartMate 3 inflow cannula direction shows no significant association with 3-year survival.
Why the study?
The influence of inflow cannula direction in HeartMate 3 remains unclear.
Does the direction of the inflow cannula affect survival or complication rates in patients undergoing HeartMate 3 left ventricular assist device implantation?
Cohort (n=48)
No
Does the direction of the inflow cannula affect survival or complication rates in patients undergoing HeartMate 3 left ventricular assist device implantation?
While the direction of the inflow cannula in HeartMate 3 LVADs is largely determined by preoperative anatomical features like mitral valve height and thoracic depth, it does not significantly impact mid-term survival or overall complication rates.
Answers are grounded in this paper and cite their sources.
Inflow cannula direction need not alter HeartMate 3 implant strategy; leaves open effects on complications or hemodynamics.
BACKGROUND: The influence of inflow cannula (IC) direction in HeartMate 3 (HM3) remains unclear. We investigated preoperative anatomical characteristics related to IC direction by analyzing computed tomography (CT) images and assessed the relationship between prognosis and IC direction in HM3. METHODS: We evaluated 48 patients who underwent HM3 implantation and categorized them based on the IC direction: anterior/lateral wall (group A, n = 18), mitral/aortic valve (B, n = 21), and posterior/inferior wall (C, n = 9). In preoperative CT, the positional relationship between the mitral valve, left ventricle (LV) apex, chest wall, and diaphragm was evaluated. The survival rate and freedom rate from complications after HM3 implantation in each group were evaluated. RESULTS: On preoperative CT, group A had a higher mitral valve height from the LV apex than group B (68 ± 13 and 52 ± 14 mm, respectively; p < 0.01). Group C had a longer distance between the LV apex and chest wall than group B (20 ± 9 and 9 ± 6 mm, p < 0.01). Group C had a shorter thoracic depth from the LV apex than did group B (24 ± 9 and 39 ± 11 mm, p < 0.01). The 3-year survival rates after HM3 implantation for groups A, B, and C were 88%, 90%, and 100%, respectively. The rates of freedom from complications after HM3 implantation at 3 years in groups A, B, and C were 50%, 43%, and 20%, respectively. CONCLUSIONS: The IC direction in HM3 was influenced by the preoperative position of the mitral valve, LV apex, chest wall, and diaphragm. The IC direction in HM3 did not significantly affect survival rates.
No takes yet. Share an insight, caveat, or question.
Imaoka et al. (2025) conducted a cohort in Heart failure requiring HeartMate 3 LVAD (n=48). Inflow cannula direction (anterior/lateral or posterior/inferior wall) vs. Inflow cannula directed toward mitral/aortic valve was evaluated on 3-year survival rate (p=0.67). The inflow cannula direction in HeartMate 3, which was influenced by preoperative anatomical characteristics, did not significantly affect 3-year survival rates (88%, 90%, and 100% across groups; p=0.67).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: